Filing Details
- Accession Number:
- 0001209191-20-041566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-07 19:25:52
- Reporting Period:
- 2020-07-02
- Accepted Time:
- 2020-07-07 19:25:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1673776 | H Steven Stein | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-02 | 6,661 | $0.00 | 105,015 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2020-07-02 | 1,474 | $106.47 | 103,541 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-07-06 | 269 | $107.79 | 103,272 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-07-06 | 2,522 | $106.40 | 100,750 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-06 | 596 | $83.83 | 101,346 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-06 | 596 | $107.31 | 100,750 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-06 | 12,132 | $83.83 | 112,882 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-06 | 12,132 | $107.31 | 100,750 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-06 | 10,437 | $72.27 | 111,187 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-06 | 10,437 | $107.31 | 100,750 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-07-06 | 10,437 | $68.62 | 111,187 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-06 | 10,437 | $107.31 | 100,750 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2020-07-02 | 12,743 | $0.00 | 12,743 | $106.47 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-07-06 | 596 | $0.00 | 596 | $83.83 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-07-06 | 12,132 | $0.00 | 12,132 | $83.83 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-07-06 | 10,437 | $0.00 | 10,437 | $72.27 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-07-06 | 10,437 | $0.00 | 10,437 | $68.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,743 | 2030-07-01 | No | 4 | A | Direct | |
| 0 | 2026-07-14 | No | 4 | M | Direct | |
| 1,194 | 2026-07-14 | No | 4 | M | Direct | |
| 12,335 | 2029-01-03 | No | 4 | M | Direct | |
| 12,334 | 2028-07-01 | No | 4 | M | Direct |
Footnotes
- Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Steven Stein's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $105.52 - $107.29.
- Represents weighted average sale price. Actual sale prices ranged from $105.64 - $108.24.
- Represents weighted average sale price. Actual sale prices ranged from $105.65 - $108.48
- Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 96,857 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
- Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years.
- Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Billionaire Hedge Funds
